Imipramine Hcl Tablets

— THERAPEUTIC CATEGORIES —
  • Mood disorders
  • Overactive bladder/enuresis

Imipramine Hcl Tablets Generic Name & Formulations

General Description

Imipramine HCl 10mg, 25mg, 50mg.

Pharmacological Class

Tricyclic.

See Also

How Supplied

Contact supplier

Mechanism of Action

The exact mechanism of action is not known. However, it does not act primarily by stimulation of the central nervous system. The clinical effect is hypothesized as being due to potentiation of adrenergic synapses by blocking uptake of norepinephrine at nerve endings. Its mechanism of action in controlling childhood enuresis is thought to be apart from its antidepressant effect.

Imipramine Hcl Tablets Indications

Indications

Depression.

Imipramine Hcl Tablets Dosage and Administration

Adult

Outpatients: initially 75mg/day, may increase to 150mg/day; max 200mg/day. Maintenance: 50–150mg/day. Inpatients: initially 100mg/day, may increase to 200mg/day as needed; max 300mg/day. Adolescents or elderly: initially 30–40mg/day; max 100mg/day.

Children

Not established.

Imipramine Hcl Tablets Contraindications

Contraindications

During or within 14 days of MAOIs. Concomitant linezolid or IV methylene blue. Acute post-MI.

Imipramine Hcl Tablets Boxed Warnings

Boxed Warning

Suicidality and antidepressant drugs.

Imipramine Hcl Tablets Warnings/Precautions

Warnings/Precautions

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening or unusual changes. Monitor for emergence of serotonin syndrome; discontinue if occurs. Screen for bipolar disorder. Cardiovascular disease. Increased intraocular pressure. Urinary retention. Hyperthyroidism. Seizure disorder. Angle-closure glaucoma. Mania/hypomania. Psychosis. ECT. Diabetes. Renal or hepatic impairment. Perform leukocyte and blood counts if fever and sore throat develops. Discontinue prior to surgery or evidence of pathological neutrophil depression. Write ℞ for smallest amount feasible. Elderly. Pregnancy. Nursing mothers: not recommended.

Imipramine Hcl Tablets Pharmacokinetics

Metabolism

Hepatic.

Elimination

Renal. Half-life: 12 hours.

Imipramine Hcl Tablets Interactions

Interactions

See Contraindications. Increased risk of serotonin syndrome with other serotonergic drugs (eg, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Potentiates alcohol, sympathomimetics (eg, epinephrine, norepinephrine), CNS depressants. Potentiated by methylphenidate, CYP2D6 inhibitors; monitor plasma levels with cimetidine, fluoxetine, quinidine, SSRIs, phenothiazines, type 1C antiarrhythmics (eg, propafenone, flecainide). Antagonized by barbiturates, phenytoin. Paralytic ileus with anticholinergics. Blocks guanethidine, clonidine. Possible cardiotoxicity with concomitant thyroid medications.

Imipramine Hcl Tablets Adverse Reactions

Adverse Reactions

Drowsiness, anticholinergic effects, CNS overstimulation, arrhythmias, extrapyramidal symptoms, hypo- or hypertension, nausea, fatigue, rash, increased perspiration, headache, changes in blood sugar, photosensitivity, edema, blood dyscrasias (discontinue if occurs), jaundice.

Imipramine Hcl Tablets Clinical Trials

See Literature

Imipramine Hcl Tablets Note

Notes

Formerly known under the brand name Tofranil.

Imipramine Hcl Tablets Patient Counseling

See Literature

Imipramine Hcl Tablets Generic Name & Formulations

General Description

Imipramine HCl 10mg, 25mg, 50mg.

Pharmacological Class

Anticholinergic.

See Also

    How Supplied

    Contact supplier

    Mechanism of Action

    The exact mechanism of action is not known. However, it does not act primarily by stimulation of the central nervous system. The clinical effect is hypothesized as being due to potentiation of adrenergic synapses by blocking uptake of norepinephrine at nerve endings. Its mechanism of action in controlling childhood enuresis is thought to be apart from its antidepressant effect.

    Imipramine Hcl Tablets Indications

    Indications

    Childhood enuresis.

    Imipramine Hcl Tablets Dosage and Administration

    Adult

    Not applicable.

    Children

    <6yrs: not established. ≥6yrs: initially 25mg daily 1 hour before bedtime; after 1 week, increase to 50mg for children 6–12yrs, up to 75mg for those >12yrs. Early night bedwetters: give 25mg in afternoon and repeat at bedtime. Max 2.5mg/kg per day. Attempt drug-free periods after gradual tapering of dose if drug response favorable.

    Imipramine Hcl Tablets Contraindications

    Contraindications

    During or within 14 days of MAOIs. Concomitant linezolid or IV methylene blue. Acute post-MI.

    Imipramine Hcl Tablets Boxed Warnings

    Boxed Warning

    Suicidality and antidepressant drugs.

    Imipramine Hcl Tablets Warnings/Precautions

    Warnings/Precautions

    Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening or unusual changes. Monitor for emergence of serotonin syndrome; discontinue if occurs. Screen for bipolar disorder. Cardiovascular disease. Increased intraocular pressure. Urinary retention. Hyperthyroidism. Seizure disorder. Angle-closure glaucoma. Mania/hypomania. Psychosis. ECT. Diabetes. Renal or hepatic impairment. Perform leukocyte and blood counts if fever and sore throat develops. Discontinue prior to surgery or evidence of pathological neutrophil depression. Write ℞ for smallest amount feasible. Elderly. Pregnancy. Nursing mothers: not recommended.

    Imipramine Hcl Tablets Pharmacokinetics

    Metabolism

    Hepatic.

    Elimination

    Renal. Half-life: 12 hours.

    Imipramine Hcl Tablets Interactions

    Interactions

    See Contraindications. Increased risk of serotonin syndrome with other serotonergic drugs (eg, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Potentiates alcohol, sympathomimetics (eg, epinephrine, norepinephrine), CNS depressants. Potentiated by methylphenidate, CYP2D6 inhibitors; monitor plasma levels with cimetidine, fluoxetine, quinidine, SSRIs, phenothiazines, type 1C antiarrhythmics (eg, propafenone, flecainide). Antagonized by barbiturates, phenytoin. Paralytic ileus with anticholinergics. Blocks guanethidine, clonidine. Possible cardiotoxicity with concomitant thyroid medications.

    Imipramine Hcl Tablets Adverse Reactions

    Adverse Reactions

    Nervousness, sleep disorders, tiredness, GI disturbances, constipation, convulsions, anxiety, emotional instability, syncope, collapse, drowsiness, orthostatic hypotension, ECG changes, restlessness, insomnia, anticholinergic effects, CNS overstimulation, extrapyramidal symptoms, rash, headache, changes in blood sugar, photosensitivity, edema, bone marrow depression (discontinue if occurs), jaundice, urinary frequency.

    Imipramine Hcl Tablets Clinical Trials

    See Literature

    Imipramine Hcl Tablets Note

    Notes

    Formerly known under the brand name Tofranil.

    Imipramine Hcl Tablets Patient Counseling

    See Literature